Ceritinib in Patients (PTS) with Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) Metastatic to the Brain and/or Leptomeninges: the Phase II Ascend-7 Study

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 26; p. i29
Main Authors Chow, L.Q., Barlesi, F., Bertino, E.M., Kim, D.-W., van den Bent, M.J., Wakelee, H., Wen, P.Y., Cazorla Arratia, P., Shen, J., Branle, F.
Format Journal Article
LanguageEnglish
Published 01.04.2015
Online AccessGet full text

Cover

Loading…
More Information
ISSN:0923-7534
DOI:10.1093/annonc/mdv050.42